Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

被引：0
|
作者：
Mori, K. [1 ]
Kamiyama, Y. [1 ]
Kondo, T. [1 ]
Kodama, T. [1 ]
机构：
[1] Tochigi Canc Ctr, Div Med Oncol Thorac, Utsunomiya, Tochigi, Japan
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71444-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6616
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [21] A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer
    Mori, Kiyoshi
    Kobayashi, Hiroyuki
    Kamiyama, Yukari
    Kano, Yasuhiko
    Kodama, Tetsuro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 73 - 78
  • [22] A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer
    Kiyoshi Mori
    Hiroyuki Kobayashi
    Yukari Kamiyama
    Yasuhiko Kano
    Tetsuro Kodama
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 73 - 78
  • [23] A phase II study of single-agent gemcitabine as a second-line treatment in advanced non-small cell lung cancer
    Cho, KH
    Song, YB
    Choi, IS
    Cho, EH
    Choi, JW
    Ahn, YM
    Roh, YH
    Nam, SH
    Kim, BS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (01) : 50 - 54
  • [24] Gemcitabine and Paclitaxel Combination as Second-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Phase II Study
    Dazzi, Claudio
    Cariello, Anna
    Casanova, Claudia
    Verlicchi, Alberto
    Montanari, Marco
    Papiani, Giorgio
    Freier, Eva
    Mazza, Valentina
    Milandri, Carlo
    Gamboni, Alessandro
    Papi, Maximilian
    Leoni, Maurizio
    Cruciani, Giorgio
    Vertogen, Bernadette
    CLINICAL LUNG CANCER, 2013, 14 (01) : 28 - 33
  • [25] Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens
    Ugur Coskun
    Ali Osman Kaya
    Süleyman Buyukberber
    Mustafa Benekli
    Aytug Uner
    Mustafa Dikilitas
    Banu Ozturk
    Ramazan Yildiz
    Secil Ozkan
    Emel Yaman
    Deniz Yamac
    Medical Oncology, 2008, 25 : 133 - 136
  • [26] Phase II study of the combination chemotherapy with weekly carboplatin and gemcitabine in advanced non-small cell lung cancer
    Mori, K.
    Kamiyama, Y.
    Kasai, H.
    Kodama, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 524 - 524
  • [27] Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer:: A phase II trial
    Crinò, L
    Mosconi, AM
    Scagliotti, GV
    Selvaggi, G
    Rinaldi, M
    Della Giulia, M
    Gridelli, C
    Calandri, C
    De Marinis, F
    Noseda, M
    Tonato, M
    SEMINARS IN ONCOLOGY, 1998, 25 (04) : 23 - 26
  • [28] Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial
    Dongiovanni, V
    Buffoni, L
    Berruti, A
    Dongiovanni, D
    Grillo, R
    Barone, C
    Addeo, A
    Camilla, F
    Bertetto, O
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (02) : 203 - 209
  • [29] Randomized Phase II Study of Belotecan or Topotecan as Second-Line Chemotherapy after Platinum Based Chemotherapy for Small Cell Lung Cancer
    Yoon, Shinkyo
    Lee, Dae Ho
    Choi, Chang-Min
    Lee, Jae Cheol
    Lee, Jung-Shin
    Kim, Sang We
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S787 - S788
  • [30] Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial
    Vincenzo Dongiovanni
    Lucio Buffoni
    Alfredo Berruti
    Diego Dongiovanni
    Raffaella Grillo
    Carla Barone
    Alfredo Addeo
    Camilla Fissore
    Oscar Bertetto
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 203 - 209
12345